199 related articles for article (PubMed ID: 29110943)
21. Prediction of histological grade of hepatocellular carcinoma using quantitative diffusion-weighted MRI: a retrospective multivendor study.
Ogihara Y; Kitazume Y; Iwasa Y; Taura S; Himeno Y; Kimura T; Sawano S; Terada S; Tanabe M; Saida Y; Tateishi U
Br J Radiol; 2018 Apr; 91(1084):20170728. PubMed ID: 29271235
[TBL] [Abstract][Full Text] [Related]
22. Diffusion-weighted MRI Before and After Robotic Radiosurgery (Cyberknife®) in Primary and Secondary Liver Malignancies: A Pilot Study.
Schmid-Tannwald C; Strobl FF; Theisen D; Muacevic A; Stintzing S; Reiser MF; Trumm CG
Technol Cancer Res Treat; 2015 Apr; 14(2):191-9. PubMed ID: 24502549
[TBL] [Abstract][Full Text] [Related]
23. Dynamic Contrast Enhanced-MRI and Apparent Diffusion Coefficient Quantitation for Differentiate Hepatocellular Carcinoma from Hepatocellular Adenoma.
Alareer HSN; Jasim Taher H; Dinar Abdullah A
Asian Pac J Cancer Prev; 2024 Mar; 25(3):931-937. PubMed ID: 38546075
[TBL] [Abstract][Full Text] [Related]
24. Quantitative evaluation of diffusion-weighted magnetic resonance imaging of focal hepatic lesions.
Sun XJ; Quan XY; Huang FH; Xu YK
World J Gastroenterol; 2005 Nov; 11(41):6535-7. PubMed ID: 16425430
[TBL] [Abstract][Full Text] [Related]
25. Prognostic prediction of apparent diffusion coefficient obtained by diffusion-weighted MRI in mass-forming intrahepatic cholangiocarcinoma.
Yamada S; Morine Y; Imura S; Ikemoto T; Arakawa Y; Saito Y; Yoshikawa M; Miyazaki K; Shimada M
J Hepatobiliary Pancreat Sci; 2020 Jul; 27(7):388-395. PubMed ID: 32162483
[TBL] [Abstract][Full Text] [Related]
26. Contribution of diffusion-weighted magnetic resonance imaging in the characterization of hepatocellular carcinomas and dysplastic nodules in cirrhotic liver.
Xu PJ; Yan FH; Wang JH; Shan Y; Ji Y; Chen CZ
J Comput Assist Tomogr; 2010 Jul; 34(4):506-12. PubMed ID: 20657216
[TBL] [Abstract][Full Text] [Related]
27. Contribution of diffusion-weighted MRI to the differential diagnosis of hepatic masses.
Demir OI; Obuz F; Sağol O; Dicle O
Diagn Interv Radiol; 2007 Jun; 13(2):81-6. PubMed ID: 17562512
[TBL] [Abstract][Full Text] [Related]
28. Differential diagnosis of benign and malignant breast masses using diffusion-weighted magnetic resonance imaging.
Min Q; Shao K; Zhai L; Liu W; Zhu C; Yuan L; Yang J
World J Surg Oncol; 2015 Feb; 13():32. PubMed ID: 25889380
[TBL] [Abstract][Full Text] [Related]
29. Differentiation of malignant thrombus from bland thrombus of the portal vein in patients with hepatocellular carcinoma: application of diffusion-weighted MR imaging.
Catalano OA; Choy G; Zhu A; Hahn PF; Sahani DV
Radiology; 2010 Jan; 254(1):154-62. PubMed ID: 20032150
[TBL] [Abstract][Full Text] [Related]
30. The Role of 18F-FDG PET/MRI in the Assessment of Primary Intrahepatic Neoplasms.
Çelebi F; Yaghouti K; Cindil E; Dogusoy GB; Tokat Y; Balcı C
Acad Radiol; 2021 Feb; 28(2):189-198. PubMed ID: 32111468
[TBL] [Abstract][Full Text] [Related]
31. High-b-value diffusion-weighted MR imaging of benign hepatocellular lesions: quantitative and qualitative analysis.
Agnello F; Ronot M; Valla DC; Sinkus R; Van Beers BE; Vilgrain V
Radiology; 2012 Feb; 262(2):511-9. PubMed ID: 22143926
[TBL] [Abstract][Full Text] [Related]
32. Diffusion kurtosis imaging of the liver at 3 Tesla: in vivo comparison to standard diffusion-weighted imaging.
Budjan J; Sauter EA; Zoellner FG; Lemke A; Wambsganss J; Schoenberg SO; Attenberger UI
Acta Radiol; 2018 Jan; 59(1):18-25. PubMed ID: 28454487
[TBL] [Abstract][Full Text] [Related]
33. Characterizing focal hepatic lesions by free-breathing intravoxel incoherent motion MRI at 3.0 T.
Watanabe H; Kanematsu M; Goshima S; Kajita K; Kawada H; Noda Y; Tatahashi Y; Kawai N; Kondo H; Moriyama N
Acta Radiol; 2014 Dec; 55(10):1166-73. PubMed ID: 24316660
[TBL] [Abstract][Full Text] [Related]
34. Primary and Metastatic Liver Malignancy: Utility Low and High B Value (1600-2000) in 3 Tesla MRI.
Göya C; Hamidi C; Önder H; Inal A; Tekbaş G; Firat U; Çetinçakmak MG
Hepatogastroenterology; 2015 Jun; 62(140):962-5. PubMed ID: 26902037
[TBL] [Abstract][Full Text] [Related]
35. Relationship between diffusion-weighted magnetic resonance imaging and histological tumor grading of hepatocellular carcinoma.
Nakanishi M; Chuma M; Hige S; Omatsu T; Yokoo H; Nakanishi K; Kamiyama T; Kubota K; Haga H; Matsuno Y; Onodera Y; Kato M; Asaka M
Ann Surg Oncol; 2012 Apr; 19(4):1302-9. PubMed ID: 21927976
[TBL] [Abstract][Full Text] [Related]
36. Gadoxetic acid-enhanced hepatobiliary phase MRI and high-b-value diffusion-weighted imaging to distinguish well-differentiated hepatocellular carcinomas from benign nodules in patients with chronic liver disease.
Lee MH; Kim SH; Park MJ; Park CK; Rhim H
AJR Am J Roentgenol; 2011 Nov; 197(5):W868-75. PubMed ID: 22021534
[TBL] [Abstract][Full Text] [Related]
37. Correlations between ADC values and molecular markers of Ki-67 and HIF-1α in hepatocellular carcinoma.
Huang Z; Xu X; Meng X; Hou Z; Liu F; Hua Q; Liu Q; Xiu J
Eur J Radiol; 2015 Dec; 84(12):2464-9. PubMed ID: 26456310
[TBL] [Abstract][Full Text] [Related]
38. Quantitative assessment of simultaneous F-18 FDG PET/MRI in patients with various types of hepatic tumors: Correlation between glucose metabolism and apparent diffusion coefficient.
Kong E; Chun KA; Cho IH
PLoS One; 2017; 12(7):e0180184. PubMed ID: 28672016
[TBL] [Abstract][Full Text] [Related]
39. Receiver operating characteristic analysis of diffusion-weighted magnetic resonance imaging in differentiating hepatic hemangioma from other hypervascular liver lesions.
Vossen JA; Buijs M; Liapi E; Eng J; Bluemke DA; Kamel IR
J Comput Assist Tomogr; 2008; 32(5):750-6. PubMed ID: 18830105
[TBL] [Abstract][Full Text] [Related]
40. Diffusion-weighted MRI and optimal b-value for characterization of liver lesions.
Kaya B; Koc Z
Acta Radiol; 2014 Jun; 55(5):532-42. PubMed ID: 23982322
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
